Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 29;10(21):5057.
doi: 10.3390/jcm10215057.

Thyroid Disfunction in Critically Ill COVID-19 Patients. Relationship with In-Hospital Mortality

Affiliations

Thyroid Disfunction in Critically Ill COVID-19 Patients. Relationship with In-Hospital Mortality

María Antonieta Ballesteros Vizoso et al. J Clin Med. .

Abstract

The incidence of thyroid disfunction has not been analyzed in critically ill COVID-19 patients. Our objective was to analyze the relationship of the thyroid profile and in-hospital mortality in critically ill COVID-19 patients. This was a prospective single-center study involving critically ill COVID-19 patients admitted to the ICU of a tertiary University Hospital. Thyroid hormones were measured through drawing blood samples from a central venous catheter at ICU admission and on the fifth day. A multiple logistic regression analysis was performed to analyze the variables associated with mortality. The ability of the different thyroid hormones to predict in-hospital mortality was evaluated by calculating the receiver operating characteristics (ROCs) and the area under the curve (AUC). A total of 78 patients were included in the study at ICU admission; 72 had their thyroid profile measured at day 5. In-hospital mortality reached 29.5%. Multiple logistic regression analysis showed that variables associated with mortality were age and prior beta-blocker therapy at ICU admission and age fT4 at day 5. The AUC for in-hospital mortality predictions of fT4 at day 5 was 0.69. Thyroid responses are commonly observed in critically ill COVID-19 patients. fT4 at day 5 after ICU admission was associated with mortality.

Keywords: COVID-19; critically ill patients; intensive care unit; mortality; thyroid hormones.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Changes in the thyroid profile over time in survivors (left) and non-survivors (right). *: p< 0.05.
Figure 2
Figure 2
Receiver operating characteristic (ROC) curves of thyroid hormones at ICU admission and day 5 to predict in-hospital mortality.

References

    1. Maiden M.J., Torpy D.J. Thyroid Hormones in Critical Illness. Crit. Care Clin. 2019;35:375–388. doi: 10.1016/j.ccc.2018.11.012. - DOI - PubMed
    1. Van den Berghe G. Non-thyroidal illness in the ICU: A syndrome with different faces. Thyroid. 2014;24:1456–1465. doi: 10.1089/thy.2014.0201. - DOI - PMC - PubMed
    1. Peeters R.P., van der Geyten S., Wouters P.J., Darras V.M., van Toor H., Kaptein E., Visser T.J., Van den Berghe G. Tissue thyroid hormone levels in critical illness. J. Clin. Endocrinol. Metab. 2005;90:6498–6507. doi: 10.1210/jc.2005-1013. - DOI - PubMed
    1. Ferrer R. COVID-19 Pandemic: The greatest challenge in the history of critical care. Med. Intensiva. 2020;44:323–324. doi: 10.1016/j.medin.2020.04.002. - DOI - PMC - PubMed
    1. Pal R., Banerjee M. COVID-19 and the endocrine system: Exploring the unexplored. J. Endocrinol. Investig. 2020;43:1027–1031. doi: 10.1007/s40618-020-01276-8. - DOI - PMC - PubMed

LinkOut - more resources